InvestorsHub Logo
Followers 31
Posts 2065
Boards Moderated 0
Alias Born 12/27/2010

Re: None

Tuesday, 02/04/2014 12:45:06 PM

Tuesday, February 04, 2014 12:45:06 PM

Post# of 701716
I heard that Merk had a steller Phase 2 results in dendritic cells similar to DCVax trial. but phase 3 has not started. its logical to think that MRK may make a run at NWBO if results are strong, why not? it may trigger bidding war too.

does anyone has insights on MRK's trial? It may be worth looking into the outcome of their phase 2. I am going to research and report here.

here is link to an article http://www.genengnews.com/gen-news-highlights/melanoma-vaccine-made-up-of-modified-dendritic-cells-shows-promise/81248516/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News